Dr. Scott A. Vota, DO

  • Mechanicsville, VA
  • Neurologist
NPI1497782320PAC ID5294739744
Medicare services, 2024
9,055
Medicare patients, 2024
682
Part D claims, 2024
692
Publications
6
Clinical trials
2
Practice address
8262 Atlee Rd, Mechanicsville, VA 23116
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Bon Secours Cancer Institute at Memorial Regional - HOPD

Acute Care Hospital outpatient department · Mechanicsville, Virginia

See all 11 affiliations

Find Dr. Vota's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Scott A. Vota is a neurologist in Mechanicsville, Virginia

Dr. Vota practices at Bon Secours Cancer Institute at Memorial Regional - HOPD in Mechanicsville, Virginia.

Dr. Vota's NPI, 1497782320, was assigned on June 27, 2006. Dr. Vota graduated from Philadelphia College of Osteopathic Medicine in 2001. Dr. Vota holds Virginia license 0102201808.

NPI and contact details
Medicare PAC ID
5294739744
NPI enumeration date
June 27, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Scott A. Vota practices at Bon Secours Cancer Institute at Memorial Regional - HOPD in Mechanicsville, Virginia

Dr. Vota's primary practice is Bon Secours Cancer Institute at Memorial Regional - HOPD, at 8262 Atlee Rd, Mechanicsville, VA 23116.

  • Bon Secours Cancer Institute at Memorial Regional - HOPD
    8262 Atlee Rd, Mechanicsville, VA 23116

Source: Dmand AI Affiliation Data

Dr. Scott A. Vota is affiliated with 9 sites of care and 2 medical groups

Dr. Vota's primary practice is Bon Secours Cancer Institute at Memorial Regional - HOPD in Mechanicsville, Virginia. Dr. Vota is also affiliated with Bon Secours Memorial Regional Medical Center. The medical group on file is Bon Secours Medical Group Richmond Specialty Care. Dmand AI also links Dr. Vota to 5 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 11 affiliations for Dr. Vota

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Scott A. Vota's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vota practices, 9 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Bon Secours Cancer Institute at Memorial Regional - HOPDAvailable with a free account
+8 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Vota practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Scott A. Vota is one of 516 neurologists in Virginia

Neurology is Dr. Vota's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Vota is licensed in Virginia.

Specialties and state licenses

  • Neurology, VirginiaPrimaryLicense 0102201808 · taxonomy 2084N0400X

Neurologists near Dr. Vota

Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.

516neurologists in Virginia
7neurologists in Mechanicsville

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Scott A. Vota billed Medicare for 9,055 services in 2024

CMS data shows 9,055 Medicare services from Dr. Vota across 18 procedure codes in 2024, for 682 Medicare patients. Medicare paid $172,394 for them.

Medicare services, 20249,055
Medicare patients682
Paid by Medicare$172,394
Procedure codes18

Dr. Vota's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 02024: 7,700
Tests and treatments
2023: 5522024: 70428%
Office and hospital visits
2023: 8892024: 60532%
Surgery
2023: 02024: 46

Where Dr. Vota's Medicare services took place, 2024

  • In an office8,50494%
  • In a facility5516%

Dr. Vota compared with the Virginia median for neurologists, 2024

  • Dr. Vota
  • Virginia median
Medicare services
9,055vs 42921.1 times
Medicare patients
682vs 2462.8 times
Part D claims
573vs 39047% above

Medians across 489 neurologists in Virginia with Dmand AI profiles that report each measure.

Dr. Vota's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vota

Need commercial claims for Dr. Vota?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vota and other neurologists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Scott A. Vota treated 682 Medicare patients in 2024, average age 76

CMS counts 682 Medicare patients who saw Dr. Vota in 2024. The largest group is 75 to 84, with 289 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vota's median patient age at 70, with 55% women.

Medicare patients, 2024682
Average age76
Average risk score1.62
Also on Medicaid7%

Dr. Vota's Medicare patients by age, 2024

Dr. Vota's Medicare patients by sex, 2024

  • Women38256%
  • Men30044%

Chronic conditions among Dr. Vota's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis62%
  4. Diabetes39%
  5. Mood disorders38%
  6. Anxiety37%
  7. Ischemic heart disease37%
  8. Chronic kidney disease35%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vota's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women55%
  • Men45%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Scott A. Vota wrote 692 Medicare Part D claims in 2024

In 2024, Dr. Vota wrote 692 Medicare Part D claims for 176 patients. 87% of them were for generic drugs. CMS names the drug for 573 of them, across 23 drugs with 11 or more claims each, at $274,757 in total drug cost. In 2023, CMS named 1,089 claims across 27 drugs.

Part D claims, 2024692
Drugs named by CMS23
Total drug cost$274,757
Part D patients176

Dr. Vota's Part D claims by kind of drug, 2024

  • Generic602 claims87%
  • Brand-name90 claims13%

Dr. Vota's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vota's Part D claims, 2024

  • Opioids2%16 of 692 claims
  • Antipsychotics, patients 65 and over2%11 of 692 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0892024: 57347%

Drugs named by CMS: 23 in 2024, 27 in 2023.

See all prescribing by Dr. Vota

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Scott A. Vota ranks in the 61st percentile for skin biopsy in Medicare

Dr. Vota accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vota as offering telehealth. CMS counts 14 procedures of skin biopsy by Dr. Vota, more than 61% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Where Dr. Vota ranks in Medicare procedure volume

Skin biopsy
61st percentile14 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find neurologists like Dr. Vota by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Scott A. Vota has 6 publications on record

Dmand AI links 6 papers to Dr. Vota, published from 2011 to 2021. The most frequent topics are Curriculum and Internship and Residency. Dr. Vota's most frequent co-authors are Raghav Govindarajan, MD, Lauren Rachel Moo, MD and Madhu Soni, MD.

Papers6
Years published2011 to 2021

Dr. Vota's papers by year, 2011 to 2021

Topics Dr. Vota writes about most

  • Curriculum
  • Internship and Residency

Dr. Vota's most frequent co-authors

Recent publications by Dr. Vota

See all 6 publications and co-authors

See who Dr. Vota researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vota works with, so you can find a warm path to the right neurologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Scott A. Vota has worked on 2 clinical trials

Dmand AI links Dr. Vota to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Charcot-Marie-Tooth disease, X-linked, 1, Muscular Dystrophy, Facioscapulohumeral and Charcot-Marie-Tooth Disease. Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA sponsors the most, 2.

Conditions in Dr. Vota's trials

  • Charcot-Marie-Tooth disease, X-linked, 1
  • Muscular Dystrophy, Facioscapulohumeral
  • Charcot-Marie-Tooth Disease
  • Muscular Dystrophies

Investigators on the most trials with Dr. Vota

Recent clinical trials with Dr. Vota

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Scott A. Vota received $8,651 in industry payments from 2019 to 2025

CMS Open Payments shows 209 general payments to Dr. Vota from 42 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 60% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $2,233.

General payments to Dr. Vota by program year, 2019 to 2025

General payments to Dr. Vota by kind, 2019 to 2025

$8.7Kin total
  • Food and beverage$5,16160%
  • Consulting fees$3,29038%
  • Education$2002%

Companies that paid Dr. Vota the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vota

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Scott A. Vota graduated from Philadelphia College of Osteopathic Medicine

Dr. Vota graduated from Philadelphia College of Osteopathic Medicine in 2001.

  1. Medical schoolPhiladelphia College of Osteopathic Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Scott A. Vota's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Scott A. Vota

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Scott A. Vota's NPI number?

Dr. Scott A. Vota's NPI number is 1497782320. It was assigned on June 27, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Scott A. Vota?

Dr. Scott A. Vota is a neurologist in Mechanicsville, Virginia. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).

Where does Dr. Scott A. Vota practice?

Dr. Vota practices at 8262 Atlee Rd, Mechanicsville, VA 23116. Dr. Vota's primary practice is Bon Secours Cancer Institute at Memorial Regional - HOPD in Mechanicsville, Virginia. Dmand AI also links Dr. Vota to 5 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. Scott A. Vota's medical license number?

Dr. Vota holds Virginia license 0102201808.

Which hospitals is Dr. Scott A. Vota affiliated with?

Dr. Vota is affiliated with Bon Secours Memorial Regional Medical Center. Dmand AI links Dr. Vota to 5 more hospitals.

What medical group is Dr. Scott A. Vota part of?

Dr. Vota is linked to Bon Secours Medical Group Richmond Specialty Care. Dmand AI links Dr. Vota to 1 more medical group.

Does Dr. Scott A. Vota accept Medicare?

Yes. CMS data shows Dr. Vota billed Medicare for 9,055 services in 2024, and Dr. Vota accepts Medicare assignment.

Does Dr. Scott A. Vota offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Vota as offering telehealth services.

How many Medicare patients does Dr. Scott A. Vota see?

CMS counts 682 Medicare patients who saw Dr. Vota in 2024, with an average age of 76.

What services does Dr. Scott A. Vota bill to Medicare?

In 2024, Dr. Vota's most billed Medicare services were injected or infused drug (J0585), nerve and brain test (95886) and hospital inpatient care (99223).

Show 6 more questionsShow fewer questions

Where did Dr. Scott A. Vota go to medical school?

Dr. Vota graduated from Philadelphia College of Osteopathic Medicine in 2001.

What drugs does Dr. Scott A. Vota prescribe most?

In 2024 Medicare Part D data, Dr. Vota's most prescribed drugs by claims were Donepezil HCl, Gabapentin and Primidone.

Has Dr. Scott A. Vota received payments from drug or device companies?

CMS Open Payments shows $8,651 in general payments to Dr. Vota from 42 companies from 2019 to 2025. The largest total came from Mitsubishi Tanabe Pharma America, Inc.

How long has Dr. Scott A. Vota been practicing?

Dr. Vota graduated from medical school in 2001, 25 years ago.

Does Dr. Scott A. Vota do research?

Dmand AI links 6 publications to Dr. Vota, published from 2011 to 2021. Dr. Vota has worked on 2 clinical trials.

Who does Dr. Scott A. Vota publish with?

Dr. Vota's most frequent co-authors are Raghav Govindarajan, MD (2 shared papers), Lauren Rachel Moo, MD (2 shared papers) and Madhu Soni, MD (2 shared papers).

Selling to neurology practices?

See neurologists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)